Home / Recalls / GenoGenix LLC / D-0065-2026

D-0065-2026 Class II Ongoing

Recalled by GenoGenix LLC — Boca Raton, FL

Recall Details

Product Type
Drugs
Report Date
October 15, 2025
Initiation Date
July 30, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

NAD+ (Nicotinamide adenine dinucleotide), a) 50 mg/mL, b) 100 mg/mL, 10 mL multi-dose vials, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

US Nationwide.

Code Information

All lots within expiry.

Other recalls by GenoGenix LLC

  • D-0049-2026 Class II — Calcium Chloride for Injection, all strengths and presentations, GenoGenix, LLC, (July 30, 2025)
  • D-0060-2026 Class II — Lipo MIC +B12 Methylcobalamin for Injection, all strengths and presentations, Ge (July 30, 2025)
  • D-0057-2026 Class II — L-Carnitine for Injection, all strengths and presentations, GenoGenix, LLC, 2840 (July 30, 2025)
  • D-0061-2026 Class II — Lysine for Injection, all strengths and presentations, GenoGenix, LLC, 2840 NW 2 (July 30, 2025)
  • D-0040-2026 Class II — Ascorbic Acid (Vitamin C) for Injection, Preservative Free, all strengths and pr (July 30, 2025)
  • D-0041-2026 Class II — Ascorbic Acid (Vitamin C) for Injection, Preserved, all strengths and presentati (July 30, 2025)
  • D-0090-2026 Class II — Sermorelin Lyophilized powder for reconstitution, 10mg, Vial capacity 10 mL Mult (July 30, 2025)
  • D-0039-2026 Class II — Amino Blend for Injection, all strengths and presentations, GenoGenix, LLC, 2840 (July 30, 2025)
  • D-0069-2026 Class II — Vitamin D3 for Injection, all strengths and presentations, GenoGenix, LLC, 2840 (July 30, 2025)
  • D-0054-2026 Class II — Glycine for Injection, all strengths and presentations, GenoGenix LLC, 2840 NW 2 (July 30, 2025)